Dear eFOI user,
Thank you for your request dated Sept. 16, 2024, with Tracking Number #PDEA-181678884950, made under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch.
You have requested the information on statistics of prescribed opioid use in the Philippines.
I am pleased to inform you that your FOI request has been approved.
You may access the list of dangerous drugs preparations that are commercially available in the country in the PDEA Official Website, under: Philippine Dangerous Drugs Preparation List as of July 1, 2024.
However, please note that this is the only information we can provide. In regard to demographics of opioid users and those with prescriptions, including trends of the opioid market, among others, there is no available information. our Compliance Service does not conduct surveys. It is only through surveys that we can obtain data of such nature.
If you are dissatisfied with our response to your FOI request, you have the option to request an internal review. To initiate this process, kindly submit your written appeal for review addressed to [insert name of Secretary and postal/e-mail address]. Please provide a detailed explanation of your dissatisfaction with our response within 15 calendar days from the date of receiving this response. We will conduct the review and communicate the outcome within 30 calendar days from the receipt of your review request.
Should you remain unsatisfied with the review outcome, you retain the right to appeal to the Office of the President under Administrative Order No. 22 (s. 2011).
Thank you.
Respectfully,
Glenn Malapad
FOI Officer
Philippine Drug Enforcement Agency
